6566-40-1

Basic information

• Product Name: 4-OXO-1,2,3,4-TETRAHYDRO-NAPHTHALENE-2-CARBOXYLIC ACID
• Synonyms: 4-OXO-1,2,3,4-TETRAHYDRO-NAPHTHALENE-2-CARBOXYLIC ACID;1,2,3,4-tetrahydro-4-oxo-2-Naphthalenecarboxylic acid
• CAS NO: 6566-40-1
• Molecular Formula: C₁₁H₁₀O₃
• Molecular Weight: 190.1953
• Mol File: 6566-40-1.mol
• Article Data: 9

Chemical Properties

• Melting Point: 143-145 °C
• Boiling Point: 393.3°Cat760mmHg
• Flash Point: 205.8°C
• Appearance: /
• Density: 1.311g/cm³
• Vapor Pressure: 4.48E-11mmHg at 25°C
• Refractive Index: 1.623
• PKA: 4.19±0.20(Predicted)
• CAS DataBase Reference: 4-OXO-1,2,3,4-TETRAHYDRO-NAPHTHALENE-2-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 4-OXO-1,2,3,4-TETRAHYDRO-NAPHTHALENE-2-CARBOXYLIC ACID(6566-40-1)
• EPA Substance Registry System: 4-OXO-1,2,3,4-TETRAHYDRO-NAPHTHALENE-2-CARBOXYLIC ACID(6566-40-1)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• Hazardous Substances Data: 6566-40-1(Hazardous Substances Data)

Usage

General Description

4-OXO-1,2,3,4-TETRAHYDRO-NAPHTHALENE-2-CARBOXYLIC ACID is a chemical compound with the molecular formula C13H12O3. It is a naphthalene derivative and is also known as 4-keto-TETRAN or 4-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid. 4-OXO-1,2,3,4-TETRAHYDRO-NAPHTHALENE-2-CARBOXYLIC ACID has potential applications in the fields of pharmaceuticals and agrochemicals. It is a key intermediate in the synthesis of various drugs and other bioactive compounds. Additionally, it has been investigated for its anti-inflammatory and anti-bacterial properties. Overall, 4-OXO-1,2,3,4-TETRAHYDRO-NAPHTHALENE-2-CARBOXYLIC ACID is a versatile chemical with diverse potential applications in the pharmaceutical and agricultural industries.

InChI:InChI=1/C20H26N4OS/c1-2-21-20(26)23-22-15-18-9-8-17(14-16-6-4-3-5-7-16)19(18)24-10-12-25-13-11-24/h3-7,14-15H,2,8-13H2,1H3,(H2,21,23,26)

Upstream product

• 205931-39-1 3,4-Dihydro-3-[(4-phenyl-1-piperazinyl)-methyl]-1-(2H)-naphthalenone, monohydrochloride 
• 109554-51-0 3-phenyl-1,2,2-propanetricarboxylic acid 1,2,2-triethyl ester 
• 42361-63-7 3-phenyl-propane-1,2,2-tricarboxylic acid 
• 100-52-7 benzaldehyde 
• 65756-81-2 (Z)-2-benzylidenesuccinic acid 
• 65756-82-3 Z-methyl 4-(phenyl)-3-methoxycarbonylbut-3-enoate 
• 75-15-0 carbon disulfide 
• 7446-70-0 aluminium trichloride 
• 122037-64-3 benzyl-succinyl chloride 
• 36092-42-9 2-benzylsuccinic acid 
• 7664-93-9 sulfuric acid 
• 2170-03-8 itaconic acid anhydride 
• 71-43-2 benzene 
• 19544-43-5 3-benzyldihydrofuran-2,5-dione 

Downstream Products

• 6566-43-4 1.2.3.4-Tetrahydro-4-hydroxy-naphthalin-2-carbonsaeure 
• 887753-01-7 3-benzyloxycarbonylamino-1-oxo-1,2,3,4-tetrahydronaphthalene 
• 113867-24-6 (S)-4-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid 
• 113867-23-5 (R)-4-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid 
• 4711-58-4 4,5-dihydro-1H-1,4-methano-benz[c]oxepin-3-one 
• 534599-20-7 (R)-4-oxo-1,2,3,4-tetrahydronaphthalen-2-ylmetyl 4-methylbenzenesulfonate 
• 534599-19-4 (S)-4-oxo-1,2,3,4-tetrahydronaphthalen-2-ylmetyl 4-methylbenzenesulfonate 
• 534599-18-3 (R)-(-)-3-hydroxymethyl-1,2,3,4-tetrahydronaphthalen-1-one 
• 108062-78-8 4-oxo-1,2,3,4-tetrahydronaphthalen-2-ylmetyl 4-methylbenzenesulfonate 
• 88-99-3 benzene-1,2-dicarboxylic acid 
• 53440-12-3 1,2,3,4-tetrahydro-2-naphthoic acid 
• 38899-41-1 1-Benzyl-3-carboxy-3,4-dihydronaphthalin 
• 1573-91-7 3-hydroxynaphthoic acid 

Relevant articles and documents

2-Amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors

Novel compounds are provided which are glycogen phosphorylase inhibitors which are useful in treating, preventing or slowing the progression of diseases requiring glycogen phosphorylase inhibitor therapy such as diabetes and related conditions (such as hy

Design, synthesis, and structure-activity relationships of novel tetracyclic compounds as peripheral benzodiazepine receptor ligands

The peripheral benzodiazepine receptor (PBR) is pharmacologically distinct from the central benzodiazepine receptor (CBR) and has been identified in a wide range of peripheral tissues as well as in the central nervous system. Although numerous studies have been performed of it, the physiological roles and functions of the PBR are still unclear. In the present study, in exploring new types of ligands for PBR, we found that a new series of compounds having a tetracyclic ring system, which were designed from FGIN-1-27, exhibited high affinities for PBR. We prepared and evaluated them for PBR affinities. The results of binding tests showed that 12e and 12f were the most potent PBR ligands among them (12e: IC50=0.44nM, 12f: IC50=0.37nM). In this paper, we present the design, synthesis, and structure-activity relationships (SARs) of novel tetracyclic compounds.

Inhibitors of microsomal triglyceride transfer protein and method

Compounds are provided which inhibit microsomal triglyceride transfer protein and thus are useful for lowering serum lipids and treating atherosclerosis and related diseases. The compounds have the structure STR1 wherein R1 to R7, Q, X and Y are as defined herein.